Lotus Pharmaceuticals, Inc. (LTUS)
OTCMKTS · Delayed Price · Currency is USD
0.0083
+0.0029 (54.67%)
At close: Aug 8, 2025
Lumos Pharma Market Cap
Lotus Pharmaceuticals has a market cap or net worth of $21.24 million as of August 12, 2025. Its market cap has decreased by -27.88% in one year.
Market Cap
21.24M
Enterprise Value
n/a
Revenue
71.39M
Ranking
n/a
PE Ratio
0.13
Stock Price
$0.01
Market Cap Chart
Since October 4, 2006, Lotus Pharmaceuticals's market cap has decreased from 165.12M to 21.24M, a decrease of -87.14%. That is a compound annual growth rate of -10.30%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 11, 2025 | 21.24M | 33.83% |
Dec 31, 2024 | 15.87M | 26.79% |
Dec 29, 2023 | 12.51M | -57.50% |
Dec 30, 2022 | 29.45M | -41.00% |
Dec 31, 2021 | 49.91M | 54.09% |
Dec 31, 2020 | 32.39M | -23.61% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Federal National Mortgage Association | 63.47B |
Federal Home Loan Mortgage | 29.09B |
Central Bancompany | 4.19B |
First National of Nebraska | 3.67B |
Mechanics Bank | 2.67B |
Wilson Bank Holding Company | 1.80B |
Copper Property CTL Pass Through Trust | 937.50M |
First National Bank Alaska | 814.87M |